Triclocarban

Basic Information

Item Value
DrugBank ID DB11155
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 migraine disorder KG + DL
2 migraine with brainstem aura KG + DL
3 migraine with or without aura, susceptibility to KG + DL
4 ulerythema ophryogenesis KG + DL
5 atrophoderma vermiculata KG + DL
6 adrenal gland hyperfunction KG + DL
7 erectile dysfunction (disease) KG + DL
8 pulmonary hypertension KG + DL
9 leprosy KG + DL
10 sciatic neuropathy KG + DL
11 amenorrhea (disease) KG + DL
12 antithrombin deficiency type 2 KG + DL
13 lesion of sciatic nerve KG + DL
14 kyphoscoliotic heart disease KG + DL
15 factor 5 excess with spontaneous thrombosis KG + DL
16 heparin cofactor 2 deficiency KG + DL
17 keratosis pilaris KG + DL
18 Prinzmetal angina KG + DL
19 thrombophilia KG + DL
20 multifocal atrial tachycardia (disease) KG + DL
21 ancylostomiasis KG + DL
22 oral candidiasis KG + DL
23 Trichinella spiralis infectious disease KG + DL
24 idiopathic neonatal atrial flutter KG + DL
25 echinococcus granulosus infectious disease KG + DL
26 Enoplea infectious disease KG + DL
27 pulmonary hypertension, primary, autosomal recessive KG + DL
28 hyperthyroidism KG + DL
29 multiple endocrine neoplasia KG + DL
30 hypoalphalipoproteinemia KG + DL
31 hypertensive disorder KG + DL
32 candidiasis KG + DL
33 His bundle tachycardia KG + DL
34 leiomyoma KG + DL
35 obsolete patella aplasia, coxa vara, and tarsal synostosis KG + DL
36 commissural lip fistula KG + DL
37 osteoradionecrosis of the mandible KG + DL
38 oral leukoedema KG + DL
39 burning mouth syndrome KG + DL
40 malignant renovascular hypertension KG + DL
41 malignant hypertensive renal disease KG + DL
42 fibromyalgia KG + DL
43 tendinitis KG + DL
44 Raynaud disease KG + DL
45 idiopathic pulmonary arterial hypertension KG + DL
46 peripheral vascular disease KG + DL
47 pulmonary hypertension owing to lung disease and/or hypoxia KG + DL
48 pulmonary hypertension with unclear multifactorial mechanism KG + DL
49 primary avascular KG + DL
50 resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.